Deferred Tax Assets, Valuation Allowance of VERTEX PHARMACEUTICALS INC / MA from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • VERTEX PHARMACEUTICALS INC / MA Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $326,200,000, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $326,200,000 +$53,300,000 +20% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q4 2024 $272,900,000 +$6,300,000 +2.4% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q4 2023 $266,600,000 +$28,800,000 +12% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $237,800,000 +$17,400,000 +7.9% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $220,400,000 +$6,600,000 +3.1% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q4 2020 $213,800,000 +$8,608,000 +4.2% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q4 2019 $205,192,000 +$36,701,000 +22% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q4 2018 $168,491,000 -$1,384,451,000 -89% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 $204,700,000 30 Sep 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 $204,700,000 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 $204,700,000 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $1,552,942,000 -$178,244,000 -10% 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q4 2016 $1,731,186,000 +$14,837,000 +0.86% 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q4 2015 $1,716,349,000 +$306,413,000 +22% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $1,409,936,000 +$166,272,000 +13% 31 Dec 2014 10-K 16 Feb 2016 2015 FY
Q4 2013 $1,243,664,000 +$32,103,000 +2.6% 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q4 2012 $1,211,561,000 -$118,214,000 -8.9% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q4 2011 $1,329,775,000 -$38,358,000 -2.8% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q4 2010 $1,368,133,000 31 Dec 2010 10-K 22 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.